semaglutide not losing weight 10 Reasons You Are On GLP-1s Why am I not losing

Ozempic was developed for managing blood sugar levels in people with type 2 diabetes, but recent clinical studies have demonstrated its effectiveness for weight loss

Meaning These findings suggest taking GLP-1RAs may influence cancer risk, highlighting the need for long-term follow-up to understand underlying mechanisms

However, the condition carries a risk of bilateral involvement, with approximately 15% of patients developing NAION in their second eye within five years of the initial event

Still, some signs may mean there is a problem that needs medical attention

diabetes investigation 2 (3), 210217

Subcutaneous Semaglutide Therapy Subcutaneous semaglutide therapy should start at 0.25 mg once weekly and after 4 weeks, dosage can be increased to 0.5 mg once weekly